Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novel antidiabetic beta3-adrenoceptor agonists covered by Wyeth patent

March 6, 2003

AstraZeneca begins European roll-out for Crestor

March 5, 2003

Strong hypoglycemic and antiketotic activity reported following administration of CPT I inhibitor

March 5, 2003

Pfizer designs new NPY antagonists

March 5, 2003

First launch announced for Zavesca

March 4, 2003

Avandia label broadened in the U.S.

March 4, 2003

P2Y2 agonists and their potential in vaginal dryness in postmenopausal women

March 3, 2003

Emisphere reports phase IIa data for oral calcitonin

March 3, 2003

Inhibitors of aP2 and their use in diabetes and lipid disorders claimed by BMS

March 3, 2003

Lexicon Genetics identifies novel target for development of osteoporosis drugs

Feb. 28, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...